Skip to main content
. Author manuscript; available in PMC: 2011 Mar 3.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2010 Mar 3;19(3):838–843. doi: 10.1158/1055-9965.EPI-09-1112

Table 1.

Characteristics of samples with MSI status and BRAF genotyping

BRAF Wild Type N = 1232 BRAF V600E N = 65 OR (95% C.I.)

Age (years) 70.3 (sd =11.5) 73.8 (sd = 11.1) p=0.02
Range 21 - 99 45 - 93
Pack-years 33.7 (sd = 28.4) 36.4 (sd = 25.7) p=0.68
Never smoked 693 (94.8) 38 (5.2) 0.85 (0.50 – 1.44)
Ever smoked 514 (95.5) 24 (4.5) 1.00
Ashkenazi Jewish 840 (94.2) 52 (5.8) 1.87 (1.01 – 3.47)
Non-Ashkenazi Jewish 392 (96.8) 13 (3.2) 1.00
Female 593 (93.4) 42 (6.6) 1.97 (1.17 – 3.31)
Male 639 (96.5) 23 (3.5) 1.00
HRT Use 22 (93.1) 2 (6.9) 0.94 (0.21 – 4.11)
No HRT Use 417 (92.7) 33 (7.3) 1.00
Aspirin/NSAID Use 326 (95.0) 17 (5.0) 1.00 (0.56 – 1.77)
No Aspirin/NSAID Use 863 (95.0) 45 (5.0) 1.00
1° Fam Hx of CRC 123 (94.6) 7 (5.4) 1.08 (0.48 – 2.42)
No Fam Hx of CRC 1103 (95.0) 58 (5.0) 1.00
MSI-high 106 (72.1) 41 (27.9) 18.1 (10.5 – 31.2)
MSS/MSI-Low 1126 (97.9) 24 (2.1) 1.00